French biotechnology company Smart and Advanced Materials (SAM) has developed an innovative new pharmaceuticals excipient. C+2S isbased on biopolymers and is capable of easily dissolving cancer drugs or anti-inflammatories sold in powder or tablet form. The new product is effective in very low doses and is less toxic than other surfactants currently used in galenicals (such as organic solvents). It is also easier than resorting to micronization. It can be used to increase the solubility of certain drugs and to improve their stability.
展开▼
机译：法国生物技术公司Smart and Advanced Materials（SAM）开发了一种创新的新型药物赋形剂。 C + 2S基于生物聚合物，能够轻松溶解以粉末或片剂形式出售的抗癌药物或抗炎药。该新产品以非常低的剂量有效，并且毒性比目前盖仑制剂中使用的其他表面活性剂（例如有机溶剂）低。这也比诉诸微粉化容易。它可用于增加某些药物的溶解度并改善其稳定性。
展开▼
